DR
David Rabuka
Founder of Acrigen Biosciences
Berkeley, California
Overview
David Rabuka is the Founder, CEO, and President at Acrigen Biosciences in Berkeley, California. With a background in bioconjugation and protein engineering, he has held leadership roles at companies like Catalent Pharma Solutions and Redwood Bioscience, showcasing expertise in drug discovery and development.
Having founded Acrigen Biosciences and served as Global Head of R&D at Catalent Pharma Solutions, David Rabuka has demonstrated a strong track record in leading innovative biotech companies and driving advancements in chemical biology and medicinal chemistry.
Work Experience
Founder, CEO, President
2019 - Current
Acrigen Biosciences is dedicated to making gene editing safe.
Raised $1,225,000.00 from National Science Foundation and National Science Foundation.
Global Head of R&D, Chemical Biology
2014 - 2019
Catalent - Blow-Fill-Seal Sterile CDMO Business is focusing on complex clinical to commercial stage formulation and manufacturing.
Founder, CSO, President
2008 - 2014
Staff Scientist
2001 - 2004
Synthesis of novel aminoglycoside antibiotics, including exploratory research and lead optimization; Design and synthesis of novel carbohydrate building blocks to be used in conjunction with Optimer’s proprietary core technology.
Research Assistant
2000 - 2001
Synthesis of complex carbohydrates and cholesterol derivatives. Developed methodology for sialic acid glycosylation.
Education
PhD
2004 - 2008
MS
1997 - 2000
Bachelor’s Degree
1991 - 1996